NCT06423703View on ClinicalTrials.gov

A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy

PHASE3RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

March 31, 2025

Conditions
Acute Pain
Interventions
DRUG

Cebranopadol

once daily for 3 days

DRUG

Oxycodone IR

four times per day for 3 days

DRUG

Placebo

three times per day 3 days (with cebranopadol), four times per day for 3 days (placebo arm)

Trial Locations (10)

21122

RECRUITING

ALLEVIATE 2 Site 001105, Pasadena

30331

RECRUITING

ALLEVIATE 2 Site 001102, Atlanta

33613

RECRUITING

ALLEVIATE 2 Site 001103, Tampa

35660

RECRUITING

ALLEVIATE 2 Site 001108, Sheffield

66212

RECRUITING

ALLEVIATE 2 Site 001107, Overland Park

72211

RECRUITING

ALLEVIATE 2 Site 001106, Little Rock

77043

RECRUITING

Alleviate 2 001113, Houston

78240

RECRUITING

ALLEVIATE 2 Site 001111, San Antonio

78501

RECRUITING

ALLEVIATE 2 Site 001104, McAllen

84107

RECRUITING

ALLEVIATE 2 Site 001101, Salt Lake City

All Listed Sponsors
lead

Tris Pharma, Inc.

INDUSTRY